CLINICAL_TRIALS
research
· 2012-10-26
Clinical Trial Update: Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation [NA]
Summary
Clinical trial update on prophylactic piperacillin/tazobactam for neutropenia in hematopoietic stem cell transplantation patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese PLA General Hospital | Conditions: Neutropenia, Hematopoietic Stem Cell Transplantation | NA | Status: UNKNOWN